FDA Inspection 1263508 — Brandon K. Lenox D.O..

Brandon K. Lenox D.O.. — FEI 3034528062

The FDA completed an inspection of Brandon K. Lenox D.O.. on Feb 27, 2025 in Maitland, FL. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI)
End Date
Feb 27, 2025
Fiscal Year
2025
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Maitland, FL (United States)

Additional Details

Clinical Investigator (CI)